November 29, 2019   Diabetes Drugs and Cardiorenal Protection: Trials and Indications CV outcomes trials of diabetes drugs have led to label expansions and guideline endorsements. Which trials and which drugs? (©Waldemarus/Shutterstock.com) Read more 5 Top Diabetes Apps for Patients and their PCPs Help your patients with diabetes help themselves. See 5 apps at-a-glance you can discuss at the next visit. Read more Treatment Intensification in Type 2 Diabetes: 3 Cases When intensifying T2DM therapy to reach glycemic goals, newer agents target common comorbidities. Which would you choose in these 3 scenarios? Read more After Metformin: Which Class Would You Choose? In this older patient with T2DM, HFpEF, and other comorbidities, which class of medication is most appropriate--and guideline-recommended? Read more